These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10220753)

  • 1. [The treatment of Parkinson disease].
    Jiménez-Jiménez FJ
    Med Clin (Barc); 1999 Feb; 112(7):257-8. PubMed ID: 10220753
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenesis imperfecta.
    Friedman JH
    Med Health R I; 2002 Jul; 85(7):198. PubMed ID: 12182087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Depressive syndrome, psychoses, dementia: frequent manifestations in Parkinson disease].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):11. PubMed ID: 15977623
    [No Abstract]   [Full Text] [Related]  

  • 5. Pramipexole-induced psychosis in Parkinson's disease.
    Li CT; Tsai SJ; Hwang JP
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH
    J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)].
    Danielczyk W
    Wien Klin Wochenschr; 1981 Aug; 93(15):500-1. PubMed ID: 7303692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental disorders in Parkinson's disease.
    Rafal R
    R I Med J (1976); 1986 Jul; 69(7):323-6. PubMed ID: 3462889
    [No Abstract]   [Full Text] [Related]  

  • 9. Medications for Parkinson's disease.
    Whitney CM
    Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
    [No Abstract]   [Full Text] [Related]  

  • 10. Amantadine and other antiglutamate agents: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S13-22. PubMed ID: 12211136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of later phases of Parkinson disease].
    Tison F
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F85-8. PubMed ID: 18680823
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.
    Papapetropoulos S
    Clin Neuropharmacol; 2006; 29(1):59. PubMed ID: 16518136
    [No Abstract]   [Full Text] [Related]  

  • 13. GSK's Requip slow the loss of dopamine function in Parkinson's disease.
    Aviat Space Environ Med; 2002 Jul; 73(7):733. PubMed ID: 12137117
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in Parkinson's disease.
    Vécsei L
    Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatments in the early stage of Parkinson disease].
    Rascol O
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F77-84. PubMed ID: 18680822
    [No Abstract]   [Full Text] [Related]  

  • 18. [Parkinson disease].
    Moore AP; Clarke CE
    Praxis (Bern 1994); 2001 Jun; 90(23):1041-6. PubMed ID: 11447724
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up (24 months) of quetiapine treatment in drug-induced Parkinson disease psychosis.
    Klein C; Prokhorov T; Miniovich A; Dobronevsky E; Rabey JM
    Clin Neuropharmacol; 2006; 29(4):215-9. PubMed ID: 16855423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of current Parkinson's disease therapy.
    Rascol O; Payoux P; Ory F; Ferreira JJ; Brefel-Courbon C; Montastruc JL
    Ann Neurol; 2003; 53 Suppl 3():S3-12; discussion S12-5. PubMed ID: 12666094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.